Difference between revisions of "File:Tab3 D'Cruz FrontCellDevBio2020 8.jpg"

Latest revision as of 18:15, 9 June 2020

Description	Tab. 3Summary of main testing methods for COVID-19 highlighting the patient sample required for testing, material being tested, and key features.
Source	D'Cruz, R.J.; Currier, A.W.; Sampson, V.B. (2020). "Laboratory testing methods for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)". Frontiers in Cell and Developmental Biology 8: 468. doi:10.3389/fcell.2020.00468.
Date	2020
Author	D'Cruz, R.J.; Currier, A.W.; Sampson, V.B.
Permission (Reusing this file)	Creative Commons Attribution 4.0 International
Other versions

This work is licensed under the Creative Commons Attribution 4.0 License.

Click on a date/time to view the file as it appeared at that time.

	Date/Time	Thumbnail	Dimensions	User	Comment
current	18:14, 9 June 2020		1,143 × 958 (373 KB)	Shawndouglas (talk \| contribs)

You cannot overwrite this file.

The following page uses this file:

This file contains additional information, probably added from the digital camera or scanner used to create or digitize it.

If the file has been modified from its original state, some details may not fully reflect the modified file.

Image title	x-repair: Following the first reports of coronavirus disease-19 (COVID-19) by China to the World Health Organization (WHO) on 31st December 2019, more than 4,302,774 novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cases have been reported by authorities in 212 countries and territories by 12th May 2020.
Author	Valerie B. Sampson
Orientation	Normal
Horizontal resolution	72 dpi
Vertical resolution	72 dpi
Software used	Adobe Photoshop CS6 (Windows)
File change date and time	10:44, 29 May 2020
Color space	Uncalibrated
Date and time of digitizing	00:22, 29 May 2020
Date metadata was last modified	16:14, 29 May 2020
Unique ID of original document	d9568da1-a341-11ea-0000-d26b489550d7
Short title	Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Keywords	coronavirus RT-PCR EIA lateral flow diagnostics convalescent plasma

@@ Line 1: / Line 1: @@
+==Summary==
+{{Information
+|Description='''Tab. 3'''Summary of main testing methods for COVID-19 highlighting the patient sample required for testing, material being tested, and key features.
+|Source={{cite journal |title=Laboratory testing methods for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |journal=Frontiers in Cell and Developmental Biology |author=D'Cruz, R.J.; Currier, A.W.; Sampson, V.B. |volume=8 |at=468 |year=2020 |doi=10.3389/fcell.2020.00468}}
+|Author=D'Cruz, R.J.; Currier, A.W.; Sampson, V.B.
+|Date=2020
+|Permission=[http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International]
+}}
 == Licensing ==
 {{cc-by-4.0}}